المؤلفون: van Bruggen FH; Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Centre Groningen (UMCG), PO Box 196, Groningen, AD, 9700, The Netherlands., Zuidema SU; Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Centre Groningen (UMCG), PO Box 196, Groningen, AD, 9700, The Netherlands., Luijendijk HJ; Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Centre Groningen (UMCG), PO Box 196, Groningen, AD, 9700, The Netherlands. h.j.luijendijk@umcg.nl.

المصدر: BMC medical research methodology [BMC Med Res Methodol] 2024 Jun 22; Vol. 24 (1), pp. 137. Date of Electronic Publication: 2024 Jun 22.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968545 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2288 (Electronic) Linking ISSN: 14712288 NLM ISO Abbreviation: BMC Med Res Methodol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal*/therapeutic use , Antibodies, Monoclonal*/adverse effects , Cholesterol, LDL*/blood , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/adverse effects, Humans ; Male ; Randomized Controlled Trials as Topic ; Female ; Treatment Outcome ; Middle Aged ; Hypercholesterolemia/drug therapy ; Hypercholesterolemia/blood ; PCSK9 Inhibitors/therapeutic use ; Aged ; Proprotein Convertase 9

المؤلفون: Park SY; Department of Endocrinology and Metabolism, Kyung Hee University Hospital, Seoul 02447, Republic of Korea.; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea., Jun JE; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea., Jeong IK; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea., Ahn KJ; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea., Chung HY; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea., Hwang YC; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Jun 17; Vol. 109 (7), pp. 1883-1890.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/blood , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Drug Therapy, Combination* , Ezetimibe*/therapeutic use , Ezetimibe*/administration & dosage , Anticholesteremic Agents*/administration & dosage , Anticholesteremic Agents*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Republic of Korea/epidemiology ; Cholesterol, LDL/blood ; Myocardial Infarction/epidemiology ; Myocardial Infarction/prevention & control ; Stroke/prevention & control ; Stroke/epidemiology ; Adult ; Dyslipidemias/drug therapy ; Dyslipidemias/epidemiology ; Dyslipidemias/blood ; Retrospective Studies ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/mortality

المؤلفون: Béliard S; Aix Marseille University, APHM, INSERM, INRAE, C2VN, Marseille, France (S.B., R.V.).; APHM, Department of Nutrition, Metabolic Diseases, Endocrinology, La Conception Hospital, Marseille, France (S.B., R.V.)., Saheb S; Sorbonne Université, Lipidology and Cardiovascular Prevention Unit, Hémobiothérapie Unit, APHP, Hôpital Pitié-Salpètriêre, Paris (S.S.)., Litzler-Renault S; Université de Bourgogne, Pediatric Intensive Care and Monitoring Unit, CHU Dijon, France (S.L.-R.)., Vimont A; Department of Public Health Expertise, Paris, France (A.V.)., Valero R; Aix Marseille University, APHM, INSERM, INRAE, C2VN, Marseille, France (S.B., R.V.).; APHM, Department of Nutrition, Metabolic Diseases, Endocrinology, La Conception Hospital, Marseille, France (S.B., R.V.)., Bruckert É; Centre ELLA Santé, Paris, France (E.B.)., Farnier M; PEC2, EA 7460, Université de Bourgogne, Dijon, France (M.F.)., Gallo A; Sorbonne Université, INSERM UMR1166, Lipidology and Cardiovascular Prevention Unit, Department of Nutrition, APHP, Hôpital Pitié-Salpètriêre, Paris, France (A.G.).

المصدر: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2024 Jun; Vol. 44 (6), pp. 1447-1454. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4636 (Electronic) Linking ISSN: 10795642 NLM ISO Abbreviation: Arterioscler Thromb Vasc Biol Subsets: MEDLINE

مواضيع طبية MeSH: Hyperlipoproteinemia Type II*/blood , Hyperlipoproteinemia Type II*/drug therapy , Hyperlipoproteinemia Type II*/genetics , Hyperlipoproteinemia Type II*/complications , Hyperlipoproteinemia Type II*/diagnosis , Hyperlipoproteinemia Type II*/mortality , Cholesterol, LDL*/blood , Homozygote* , Angiopoietin-Like Protein 3* , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/adverse effects, Humans ; Male ; Female ; Adult ; Middle Aged ; Blood Component Removal ; Biomarkers/blood ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal/adverse effects ; Time Factors ; Progression-Free Survival ; Young Adult ; Treatment Outcome ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/epidemiology ; Adolescent

المؤلفون: Ge Q; Institute of Quality Standard and Testing Technology of Agricultural Products, Ningxia Academy of Agriculture and Forestry Sciences, Yinchuan, China., Yan Y; Institute of Quality Standard and Testing Technology of Agricultural Products, Ningxia Academy of Agriculture and Forestry Sciences, Yinchuan, China., Luo Y; Ningxia Institute of Science and Technology Development Strategy and Information, Yinchuan, China., Teng T; Ningxia Guolong Hospital Co., LTD, Yinchuan, China., Cao C; People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China., Zhao D; Institute of Quality Standard and Testing Technology of Agricultural Products, Ningxia Academy of Agriculture and Forestry Sciences, Yinchuan, China., Zhang J; Institute of Quality Standard and Testing Technology of Agricultural Products, Ningxia Academy of Agriculture and Forestry Sciences, Yinchuan, China., Li C; Institute of Quality Standard and Testing Technology of Agricultural Products, Ningxia Academy of Agriculture and Forestry Sciences, Yinchuan, China., Chen W; Institute of Quality Standard and Testing Technology of Agricultural Products, Ningxia Academy of Agriculture and Forestry Sciences, Yinchuan, China., Yang B; Institute of Quality Standard and Testing Technology of Agricultural Products, Ningxia Academy of Agriculture and Forestry Sciences, Yinchuan, China., Yi Z; College of Food Science and Technology, Huazhong Agricultural University, Wuhan, China., Chang T; College of Food Science and Technology, Huazhong Agricultural University, Wuhan, China., Chen X; Institute of Quality Standard and Testing Technology of Agricultural Products, Ningxia Academy of Agriculture and Forestry Sciences, Yinchuan, China.

المصدر: International journal of food sciences and nutrition [Int J Food Sci Nutr] 2024 Jun; Vol. 75 (4), pp. 349-368. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9432922 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3478 (Electronic) Linking ISSN: 09637486 NLM ISO Abbreviation: Int J Food Sci Nutr Subsets: MEDLINE

مواضيع طبية MeSH: Dietary Supplements* , Hypercholesterolemia*/drug therapy , Hypercholesterolemia*/diet therapy , Anticholesteremic Agents*/pharmacology , Anticholesteremic Agents*/therapeutic use , Cholesterol, LDL*/blood, Humans ; Cholesterol/blood ; Animals ; Phytosterols/pharmacology ; Randomized Controlled Trials as Topic ; Probiotics/pharmacology ; Probiotics/therapeutic use ; Dietary Fiber/pharmacology ; Receptors, LDL/metabolism ; Berberine/pharmacology ; Berberine/therapeutic use ; Garlic

المؤلفون: Shin KH, Choi HD

المصدر: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2024 Jun; Vol. 62 (6), pp. 250-258.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN: 0946-1965 (Print) Linking ISSN: 09461965 NLM ISO Abbreviation: Int J Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Secondary Prevention*/methods , Randomized Controlled Trials as Topic* , Stroke*/prevention & control , Stroke*/epidemiology , PCSK9 Inhibitors*/therapeutic use , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/adverse effects , Cardiovascular Diseases*/prevention & control, Humans ; Primary Prevention/methods ; Treatment Outcome ; Antibodies, Monoclonal/therapeutic use ; Proprotein Convertase 9

المؤلفون: Maliwal D; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India., Pissurlenkar RRS; Department of Pharmaceutical Chemistry, Goa College of Pharmacy, Panaji, Goa, India., Telvekar V; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.

المصدر: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2024 Jun; Vol. 42 (9), pp. 4656-4667. Date of Electronic Publication: 2023 Jun 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 8404176 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-0254 (Electronic) Linking ISSN: 07391102 NLM ISO Abbreviation: J Biomol Struct Dyn Subsets: MEDLINE

مواضيع طبية MeSH: Proprotein Convertase 9*/metabolism , Proprotein Convertase 9*/chemistry , Molecular Docking Simulation* , PCSK9 Inhibitors*/chemistry , Molecular Dynamics Simulation* , Anticholesteremic Agents*/chemistry , Anticholesteremic Agents*/pharmacology, Humans ; Protein Binding ; Cholesterol/metabolism ; Cholesterol/chemistry ; Ligands ; Binding Sites ; Small Molecule Libraries/pharmacology ; Small Molecule Libraries/chemistry ; Structure-Activity Relationship

المؤلفون: Mahajan K; Department of Cardiology, Himachal Heart Institute, Mandi, Himachal Pradesh, India. Electronic address: Kunalmahajan442@gmail.com., Nagendra L; Department of Endocrinology, JSS Academy of Higher Education and Research, Mysore, India. Electronic address: drlakshminagendra@jssuni.edu.in., Dhall A; Department of Cardiology, Janakpuri Superspeciality Hospital, New Delhi, India., Dutta D; Department of Endocrinology, Center for Endocrinology Diabetes Arthritis & Rheumatism (CEDAR) Superspeciality Healthcare, Dwarka, New Delhi, India. Electronic address: deepdutta2000@yahoo.com.

المصدر: European journal of internal medicine [Eur J Intern Med] 2024 Jun; Vol. 124, pp. 99-107. Date of Electronic Publication: 2024 Feb 09.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9003220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0828 (Electronic) Linking ISSN: 09536205 NLM ISO Abbreviation: Eur J Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Acute Coronary Syndrome*/drug therapy , Acute Coronary Syndrome*/blood , Ezetimibe*/therapeutic use , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/administration & dosage , Cholesterol, LDL*/blood, Humans ; Randomized Controlled Trials as Topic ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Drug Therapy, Combination ; Treatment Outcome

المؤلفون: Lee C; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; These authors contributed equally to this work., Kwak SH; Division of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.; These authors contributed equally to this work., Han J; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea., Shin JH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Yoo B; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee YS; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea., Park JS; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea., Lim BJ; Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee JG; Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim YS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim SY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; These authors contributed equally to this work., Bae SH; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea soohanbae@yuhs.ac.; Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.; These authors contributed equally to this work.

المصدر: The European respiratory journal [Eur Respir J] 2024 May 16; Vol. 63 (5). Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: Ezetimibe*/therapeutic use , Ezetimibe*/pharmacology , Idiopathic Pulmonary Fibrosis*/drug therapy , Autophagy*/drug effects , Drug Repositioning* , Disease Models, Animal* , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/pharmacology, Animals ; Humans ; Mice ; Male ; Female ; Mice, Transgenic ; Bleomycin ; Lung/pathology ; Lung/drug effects ; Fibroblasts/metabolism ; Fibroblasts/drug effects ; Retrospective Studies ; Aged ; Middle Aged ; Mice, Inbred C57BL ; Myofibroblasts/drug effects ; Myofibroblasts/metabolism ; Cholesterol/metabolism

المؤلفون: Park IR; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea., Moon JS; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.

المصدر: Diabetes & metabolism journal [Diabetes Metab J] 2024 May; Vol. 48 (3), pp. 387-389. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Letter; Editorial

بيانات الدورية: Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2233-6087 (Electronic) Linking ISSN: 22336079 NLM ISO Abbreviation: Diabetes Metab J Subsets: MEDLINE

مواضيع طبية MeSH: Rosuvastatin Calcium*/therapeutic use , Rosuvastatin Calcium*/administration & dosage , Diabetes Mellitus, Type 2*/drug therapy , Ezetimibe*/therapeutic use , Ezetimibe*/administration & dosage , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/administration & dosage , Drug Therapy, Combination*, Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Blood Glucose/analysis ; Azetidines/therapeutic use ; Azetidines/administration & dosage ; Sulfonamides/therapeutic use ; Sulfonamides/administration & dosage ; Pyrimidines/therapeutic use ; Pyrimidines/administration & dosage

المؤلفون: Liasi E; Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus., Kantilafti M; Department of Health Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus., Hadjimbei E; Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus., Chrysostomou S; Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus. Electronic address: s.chrysostomou@euc.ac.cy.

المصدر: Semergen [Semergen] 2024 May-Jun; Vol. 50 (4), pp. 102156. Date of Electronic Publication: 2024 Feb 03.

نوع المنشور: Systematic Review; Journal Article; Review

بيانات الدورية: Publisher: Saned, S.A Country of Publication: Spain NLM ID: 9610769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8865 (Electronic) Linking ISSN: 11383593 NLM ISO Abbreviation: Semergen Subsets: MEDLINE

مواضيع طبية MeSH: Hypercholesterolemia*/drug therapy , Dietary Supplements* , Randomized Controlled Trials as Topic* , Lovastatin*/administration & dosage , Lovastatin*/adverse effects , Anticholesteremic Agents*/administration & dosage , Anticholesteremic Agents*/adverse effects , Cholesterol, LDL*/blood , Biological Products* , Dicarboxylic Acids* , Fatty Acids*, Humans ; Dose-Response Relationship, Drug ; Cholesterol/blood